Citius Pharmaceuticals, Inc. Interest Expense Nonoperating
Citius Pharmaceuticals, Inc. (CTXR) reported Interest Expense Nonoperating of $231.73 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-08-14
- Citius Pharmaceuticals, Inc. interest expense nonoperating for the quarter ending 2026-06-30 was $231.73K, a 34.52% increase year-over-year.
- Citius Pharmaceuticals, Inc. interest expense nonoperating for the quarter ending 2026-03-31 was $33.03K.
- Citius Pharmaceuticals, Inc. interest expense nonoperating for the quarter ending 2025-12-31 was $155.54K.
- Citius Pharmaceuticals, Inc. interest expense nonoperating for the quarter ending 2025-09-30 was $95.52K.
- Citius Pharmaceuticals, Inc. interest expense nonoperating for fiscal 2025 was $267.78K.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2026-06-30 | $231.73K 10-Q · filed 2026-08-14 | $264.76K derived: sum of 2 quarters · filed 2026-08-14 | $420.30K 10-Q · filed 2026-08-14 | $515.82K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $33.03K 10-Q · filed 2026-05-15 | $188.57K 10-Q · filed 2026-05-15 | $284.09K derived: sum of 3 quarters · filed 2026-05-15 | $456.35K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $155.54K 10-Q · filed 2026-02-13 | $251.06K derived: sum of 2 quarters · filed 2026-02-13 | $423.32K derived: sum of 3 quarters · filed 2026-08-14 | |
| 2025-09-30 | $95.52K derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-23 | $267.78K derived: sum of 2 quarters · filed 2026-08-14 | $267.78K 10-K · filed 2025-12-23 | |
| 2025-06-30 | $172.26K 10-Q · filed 2026-08-14 | $172.26K 10-Q · filed 2026-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |